Mark has more than 25 years of experience in the pharmaceutical, biotech and medical devices sectors. He has been the Chief Medical Officer for public and private biotech companies across a range of therapeutic indications including cardiovascular, metabolic, and rare diseases. He has substantial experience in clinical development and has been involved in all stages of interactions with FDA, EMA and other health authorities. Mark qualified with his medical degree from UCL and obtained additional qualifications (MS and FRCS) in surgery.